Atomera, Inc.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: US04965B1008
USD
2.51
0.22 (9.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Atomera, Inc. stock-summary
stock-summary
Atomera, Inc.
Miscellaneous
Atomera Incorporated, formerly MEARS Technologies, Inc., is a development-stage company. The Company is engaged in the development, commercialization and licensing of processes and technologies for the semiconductor industry. The Company's technology, named Mears Silicon Technology (MST), is a thin film of reengineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to Complementary Metal-Oxide Semiconductor (CMOS)-type transistors. MST is its performance enhancement technology. The Company's MST is a silicon-on-silicon solution that provides multiple benefits through modification to the standard CMOS manufacturing flow. MST improvements are delivered through its silicon band engineering approach that is based on the quantum mechanics of modern deep sub-micron devices.
Company Coordinates stock-summary
Company Details
750 University Ave Ste 280 , LOS GATOS CA : 95032-7698
stock-summary
Tel: 1 408 4425248
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 16 Schemes (13.49%)

Foreign Institutions

Held by 27 Foreign Institutions (2.8%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. John Gerber
Independent Chairman of the Board
Mr. Scott Bibaud
President, Chief Executive Officer, Director
Mr. Erwin Trautmann
Executive Vice President - Strategic Business Development, Director
Dr. C Cleavelin
Independent Director
Ms. Duy-Loan Le
Independent Director
Mr. Steven Shevick
Independent Director
Mr. Rolf Stadheim
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 108 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.97

stock-summary
Return on Equity

-91.25%

stock-summary
Price to Book

5.06